The company has demonstrated the adroit ability to pivot at a moment's notice...success can never be measured on one pathway (yellow brick road)...but a continued buildout of infrastructure that will cascade into a superhighway that carries a train of indications...that will end in one of two ways...a buyout after 2 BTD's ...or a brand new Oncology Pharmaceutical behemoth that owns a PLATFORM drug...it's golden either way...but, preferentially the latter.